Cargando…
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
BACKGROUND: Hepatitis C virus (HCV) treatment has undergone major changes in recent years. Previous interferon-based therapies have been replaced by oral direct-acting antivirals (DAA) regimens, with high sustained virologic response (SVR) rates, and a lower incidence of adverse events (AEs). AIM: T...
Autores principales: | Lourenço, Mariana Sandoval, Zitelli, Patricia Momoyo Y, Cunha-Silva, Marlone, Oliveira, Arthur Ivan N, Oliveira, Cláudia P, Sevá-Pereira, Tiago, Carrilho, Flair José, Pessoa, Mario G, Mazo, Daniel F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790388/ https://www.ncbi.nlm.nih.gov/pubmed/35126848 http://dx.doi.org/10.4254/wjh.v14.i1.195 |
Ejemplares similares
-
Early liver function improvement following successful treatment of chronic hepatitis C in patients with decompensated cirrhosis: a real-life study
por: Lourenço, Mariana Sandoval, et al.
Publicado: (2021) -
Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12
por: Werner, Christoph R, et al.
Publicado: (2016) -
Stages of care for patients with chronic hepatitis C at a hospital in southern Brazil
por: Vaucher, Manoela Badinelli, et al.
Publicado: (2023) -
The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C
por: Oliveira, Arthur Ivan N., et al.
Publicado: (2021) -
Liver transplant in patients with primary sclerosing cholangitis: A retrospective cohort from Northeastern Brazil
por: Freitas, Louyse Teixeira de Souza, et al.
Publicado: (2023)